Hemlibra available to Quebec patients with hemophilia A and inhibitors
May 9, 2019 – Montreal – Héma-Québec informed the Canadian Hemophilia
Society-Quebec Chapter (CHSQ) today that Hemlibra® will be available for the
treatment of patients with hemophilia A and inhibitors in Quebec in the coming
Provinces stall on access to life-changing hemophilia therapy
Montreal, May 6, 2019 – The Canadian Hemophilia Society (CHS) calls on the Provinces and Territories to stop stalling and immediately make Hemlibra (emicizumab) available to all Canadians with hemophilia A and an inhibitor to factor VIII. The case of young Callum Guthrie from Nova Scotia illustrates the urgency.